Advisory Services Network’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-604
| Closed | -$45.4K | – | 3415 |
|
|
2026
Q1 | $45.4K | Buy |
+604
| New | +$47.7K | ﹤0.01% | 2696 |
|
|
2025
Q4 | – | Sell |
-238
| Closed | -$15.5K | – | 3051 |
|
|
2025
Q3 | $15.5K | Buy |
+238
| New | +$11.6K | ﹤0.01% | 3075 |
|
|
2024
Q1 | – | Sell |
-519
| Closed | -$26.3K | – | 2545 |
|
|
2023
Q4 | $26.3K | Buy |
+519
| New | +$24.9K | ﹤0.01% | 2368 |
|
|
2023
Q2 | – | Sell |
-519
| Closed | -$18.5K | – | 2520 |
|
|
2023
Q1 | $18.5K | Sell |
519
-97
| -16% | -$3.64K | ﹤0.01% | 2582 |
|
|
2022
Q4 | $23.3K | Buy |
+616
| New | +$25.9K | ﹤0.01% | 2382 |
|
|
2021
Q3 | – | Sell |
-519
| Closed | -$21K | – | 2318 |
|
|
2021
Q2 | $21K | Buy |
+519
| New | +$20.3K | ﹤0.01% | 2479 |
|
|
2021
Q1 | – | Sell |
-1,169
| Closed | -$66K | – | 2132 |
|
|
2020
Q4 | $66K | Buy |
1,169
+595
| +104% | +$29.7K | ﹤0.01% | 1534 |
|
|
2020
Q3 | $28K | Buy |
+574
| New | +$31.9K | ﹤0.01% | 1899 |
|
|
2020
Q2 | – | Sell |
-5,183
| Closed | -$245K | – | 1881 |
|
|
2020
Q1 | $245K | Sell |
5,183
-2,607
| -33% | -$145K | 0.02% | 746 |
|
|
2019
Q4 | $471K | Buy |
7,790
+6,883
| +759% | +$410K | 0.02% | 637 |
|
|
2019
Q3 | $58K | Hold |
907
| – | – | ﹤0.01% | 1304 |
|
|
2019
Q2 | $58K | Buy |
907
+252
| +38% | +$17.8K | ﹤0.01% | 1302 |
|
|
2019
Q1 | $53K | Sell |
655
-102
| -13% | -$6.58K | ﹤0.01% | 1226 |
|
|
2018
Q4 | $41K | Buy |
757
+155
| +26% | +$7.91K | ﹤0.01% | 1216 |
|
|
2018
Q3 | $31K | Hold |
602
| – | – | ﹤0.01% | 1415 |
|
|
2018
Q2 | $28K | Sell |
602
-1,078
| -64% | -$47.8K | ﹤0.01% | 1426 |
|
|
2018
Q1 | $74K | Sell |
1,680
-248
| -13% | -$12.6K | 0.01% | 1154 |
|
|
2017
Q4 | $97K | Sell |
1,928
-1,344
| -41% | -$73.7K | 0.01% | 995 |
|
|
2017
Q3 | $166K | Buy |
3,272
+2,670
| +444% | +$140K | 0.02% | 711 |
|
|
2017
Q2 | $31K | Sell |
602
-50
| -8% | -$2.33K | ﹤0.01% | 1200 |
|
|
2017
Q1 | $26K | Buy |
+652
| New | +$29.3K | ﹤0.01% | 1187 |
|
|
2016
Q3 | $39K | Sell |
1,065
-200
| -16% | -$6.26K | 0.01% | 939 |
|
|
2016
Q2 | $29K | Hold |
1,265
| – | – | 0.01% | 932 |
|
|
2016
Q1 | $51K | Buy |
1,265
+1,250
| +8,333% | +$50.8K | 0.01% | 656 |
|
|
2015
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 1434 |
|
|
2015
Q3 | $1K | Buy |
15
+8
| +114% | +$414 | ﹤0.01% | 1422 |
|
|
2015
Q2 | $0 | Buy |
+7
| New | +$445 | ﹤0.01% | 1454 |
|
Other funds holding IONS
Advisory Services Network's IONS Position: Q2 2026 in Review
Advisory Services Network sold out of Ionis Pharmaceuticals (IONS) in Q2 2026, closing a stake of 604 shares — an estimated $45.4K sold.
Advisory Services Network first reported a position in IONS in Q2 2015 and held it in 27 quarters. The position peaked at $471K in Q4 2019. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Advisory Services Network reported no remaining Ionis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 604 Ionis Pharmaceuticals shares in Q2 2026, an estimated $45.4K.
- Advisory Services Network first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 27 quarters.
- Advisory Services Network's Ionis Pharmaceuticals position peaked at $471K in Q4 2019.
- 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.